Tata Elxsi moves up on launching material intelligence solution 'ViTel'
Tata Elxsi is currently trading at Rs. 4369.30, up by 33.30 points or 0.77% from its previous closing of Rs. 4336.00 on the BSE.
The scrip opened at Rs. 4341.45 and has touched a high and low of Rs. 4,372.45 and Rs. 4341.45 respectively. So far 38 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 6733.50 on 10-Jun-2025 and a 52 week low of Rs. 3945.00 on 14-May-2026.
Last one week high and low of the scrip stood at Rs. 4394.00 and Rs. 3,945.00 respectively. The current market cap of the company is Rs. 27012.01 crore.
The promoters holding in the company stood at 43.90%, while Institutions and Non-Institutions held 22.48% and 33.63% respectively.
Tata Elxsi has launched ViTel, a Material Intelligence solution for Medical Device manufacturers, co-developed with Viridium AI, a material intelligence platform company. ViTel is being formally introduced at DeviceTalks Boston 2026, where the company is presenting its latest advances in AI-powered MedTech engineering and compliance.
Medical device manufacturers are facing a new operating reality. Material decisions now affect margin, resilience, product velocity, and market access, yet critical product knowledge remains buried across BOMs, supplier documents, ERP and PLM systems, and expert teams. This makes every new regulation or customer requirement a costly manual exercise.
ViTel addresses this by creating a reusable Material Intelligence layer across the enterprise, helping teams identify material and supplier dependencies, assess country-of-origin and sourcing exposure, evaluate alternatives, and understand where product or material risks affect cost, continuity, or market access. Powered by Viridium AI's Knowledge Cloud, Chemical Digital Twin, and science-constrained AI models, ViTel transforms scattered enterprise data into a living product-material knowledge graph connecting products, parts, materials, chemicals, suppliers, regulations, and evidence.
